Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Approval of New Agents after Phase II TrialsBruce ChabnerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Targeted agents: the rules of combinationEunice L Kwak, Jeffrey W Clark, Bruce ChabnerTargeted Oncology|November 9, 2017
Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest DevelopmentsAiko Nagayama, Leif W Ellisen, Bruce Chabner, et al.Blood|November 26, 2002
Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cellsRamadevi Nimmanapalli, Lianne Fuino, Corinne Stobaugh, et al.The Journal of Investigative Dermatology|November 22, 2005
Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic actionChunlei Zhang, Victoria Richon, Xiao Ni, et al.Pharmacological Reviews|October 5, 2013
Pharmacokinetics, clinical indications, and resistance mechanisms in molecular targeted therapies in cancerBenjamin Izar, Julia Rotow, Justin Gainor, et al.The Oncologist|June 3, 2011
Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzleCarlo La Vecchia, Sharon H Giordano, Gabriel N Hortobagyi, et al.Bioorganic & Medicinal Chemistry Letters|May 18, 2007
Aminosuberoyl hydroxamic acids (ASHAs): a potent new class of HDAC inhibitorsSandro Belvedere, David J Witter, Jiaming Yan, et al.Journal of Cellular Biochemistry|April 27, 2004
Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acidDouglas C Marchion, Elona Bicaku, Adil I Daud, et al.The Oncologist|June 3, 2008
Lost in translation: integrating medical interpreters into the multidisciplinary teamLidia Schapira, Erika Vargas, Renzo Hidalgo, et al.Pageof 3